<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Chimeric Therapeutics Limited Temp — News on 6ix</title>
    <link>https://6ix.com/company/chimeric-therapeutics-limited-temp</link>
    <description>Latest news and press releases for Chimeric Therapeutics Limited Temp on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 29 Apr 2026 10:02:04 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/chimeric-therapeutics-limited-temp" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69eb70f9ec513269ec6fea40.webp</url>
      <title>Chimeric Therapeutics Limited Temp</title>
      <link>https://6ix.com/company/chimeric-therapeutics-limited-temp</link>
    </image>
    <item>
      <title>Quarterly Activities/Appendix 4C Cash Flow Report</title>
      <link>https://6ix.com/company/chimeric-therapeutics-limited-temp/news/quarterly-activitiesappendix-4c-cash-flow-report-331</link>
      <guid isPermaLink="true">https://6ix.com/company/chimeric-therapeutics-limited-temp/news/quarterly-activitiesappendix-4c-cash-flow-report-331</guid>
      <pubDate>Wed, 29 Apr 2026 10:02:04 GMT</pubDate>
      <description>Quarterly Activities/Appendix 4C Cash Flow Report</description>
    </item>
    <item>
      <title>CHM CORE-NK Phase 1B clinical trial achieves 60% CR/CRi</title>
      <link>https://6ix.com/company/chimeric-therapeutics-limited-temp/news/chm-core-nk-phase-1b-clinical-trial-achieves-60percent-crcri</link>
      <guid isPermaLink="true">https://6ix.com/company/chimeric-therapeutics-limited-temp/news/chm-core-nk-phase-1b-clinical-trial-achieves-60percent-crcri</guid>
      <pubDate>Mon, 27 Apr 2026 03:36:04 GMT</pubDate>
      <description>CHM CORE-NK Phase 1B clinical trial achieves 60% CR/CRi</description>
    </item>
  </channel>
</rss>